Companies: 10,795·Total market cap: $144.5T
Christina Lake Cannabis Corp.

Christina Lake Cannabis Corp.

CLC.CNCNQHealthcare● Active
$0.03
+$0.00(+0.00%)
Market Cap$7442807
P/E Ratio
52W High$0.06
52W Low$0.025

Christina Lake Cannabis Corp. (CLC.CN) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

clc.cn · pe ratio · data through Nov 30, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Christina Lake Cannabis Corp. (CLC.CN) measures how much investors pay for each dollar of the company's trailing earnings. CLC.CN's current PE ratio of 6.25x is calculated by dividing its stock price of $0.03 by its TTM earnings per share of $0.00. +5.5% elevated vs 5Y avg 5.9x

6.25x
P/E Ratio (TTM)+5.5%

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-11-30

Forward P/E
N/A
EPS (TTM)
$0.00
TTM · diluted EPS
PEG Ratio
0.02
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Christina Lake Cannabis Corp. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2015 – 2025 · Annual
PE Ratio (TTM)
5Y Avg 5.9x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Christina Lake Cannabis Corp.
Christina Lake Cannabis Corp.You
CLC.CN
$7M6.25x$0.00
Blueberries Medical Corp.
Blueberries Medical Corp.
BBM.CN
$5MN/A-$0.00
CLS Holdings USA, Inc.
CLS Holdings USA, Inc.
CLSH.CN
$8MN/A-$0.05
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
CTX.TO
$15MN/A-$0.00
Delivra Health Brands Inc.
Delivra Health Brands Inc.
DHB.V
$4MN/A-$0.04
Lobe Sciences Ltd.
Lobe Sciences Ltd.
LOBE.CN
$22MN/A-$0.03
Mydecine Innovations Group Inc.
Mydecine Innovations Group Inc.
MYCO.NE
$21MN/A-$0.05

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 11 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-11-30Latest
FY2025
7.30x$0.00+60.3%
2024-11-30
FY2024
4.55x$0.01
2023-11-30
FY2023
$-0.03
2022-11-30
FY2022
$-0.01
2021-11-30
FY2021
$-0.06
2020-11-30
FY2020
$-0.07
2019-11-30
FY2019
$-0.03
2018-11-30
FY2018
$-0.01
2017-11-30
FY2017
$-0.00
2016-11-30
FY2016
$-0.00

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Christina Lake Cannabis Corp. (CLC.CN) measures how much investors pay for each dollar of the company's trailing earnings. CLC.CN's current PE ratio of 6.25x is calculated by dividing its stock price of $0.03 by its TTM earnings per share of $0.00.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.03 ÷ $0.00 = 6.25x
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

CLC.CN pe ratio · 6 questions

CLC.CN's current PE ratio is 6.25x as of 2026-06-08, based on a stock price of $0.03 and TTM EPS of $0.00. Data sourced from Financial Modeling Prep via CLC.CN's SEC 10-K and 10-Q filings.

CLC.CN PE ratioWhat is CLC.CN PE ratioCurrent PE ratio of CLC.CNCLC.CN PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Christina Lake Cannabis Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08